4.6 Editorial Material

Consequences of COVID-19 Lockdown on the Misuse and Marketing of Addictive Substances and New Psychoactive Substances

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Infectious Diseases

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges

Chih-Cheng Lai et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)

Editorial Material Psychiatry

COVID-19: The Hidden Impact on Mental Health and Drug Addiction

Stefania Chiappini et al.

FRONTIERS IN PSYCHIATRY (2020)

Editorial Material Psychiatry

New Trends of Substance Abuse During COVID-19 Pandemic: An International Perspective

Simona Zaami et al.

FRONTIERS IN PSYCHIATRY (2020)

Review Pharmacology & Pharmacy

Addictovigilance contribution during COVID-19 epidemic and lockdown in France

Maryse Lapeyre-Mestre et al.

THERAPIE (2020)

Article Psychiatry

Addiction psychiatry and COVID-19: impact on patients and service provision

D. Columb et al.

IRISH JOURNAL OF PSYCHOLOGICAL MEDICINE (2020)

Article Pharmacology & Pharmacy

Assessing the 2004-2018 Fentanyl Misusing Issues Reported to an International Range of Adverse Reporting Systems

Fabrizio Schifano et al.

FRONTIERS IN PHARMACOLOGY (2019)

Article Pharmacology & Pharmacy

Psychoactive drugs and driving

Vanita Parekh

AUSTRALIAN PRESCRIBER (2019)

Article Pharmacology & Pharmacy

New psychoactive substances: concerted efforts and common legislative answers for stemming a growing health hazard

S. Zaami

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES (2019)

Review Biochemistry & Molecular Biology

Adulteration Practices of Psychoactive Illicit Drugs: An Updated Review

Renata Solimini et al.

CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2017)

Review Neurosciences

Recent Trends in Analytical Methods to Determine New Psychoactive Substances in Hair

Chrystalla Kyriakou et al.

CURRENT NEUROPHARMACOLOGY (2017)

Article Neurosciences

From Clinical Application to Cognitive Enhancement: The Example of Methylphenidate

Francesco Paolo Busardo et al.

CURRENT NEUROPHARMACOLOGY (2016)